Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Heart Rhythm. 2017 Oct;14(10):1466-1475. doi: 10.1016/j.hrthm.2017.06.017. Epub 2017 Jun 10.
Sudden cardiac death (SCD) due primarily to ventricular fibrillation claims 1.5 million lives worldwide each year. In 45%-50% of cases, it is the first manifestation of underlying heart disease. Traditional risk factors including smoking, hypertension, age, sex, as well as depressed left ventricular ejection fraction lack sufficient sensitivity and specificity to forewarn of impending life-threatening arrhythmias. There has been a decades-long search for electrocardiographic (ECG) markers of SCD risk. Several interval-based indices such as QT dispersion and T-T interval held initial promise but ultimately yielded mixed results. Recently, the focus has been on interlead heterogeneity of R- and T-wave morphology. The new approaches have involved advanced analytical tools including vectorcardiographic techniques and second central moment analysis of QRS-aligned templates to quantify heterogeneity of depolarization and repolarization waveforms. The results of current studies appear to be robust and worthy of further exploration. This review examines the electrophysiological underpinnings of heterogeneity-based risk assessment and provides an update of clinical techniques. We also discuss future directions whereby tracking heterogeneity may help to disclose latent risk for SCD not only in ECG recordings made at rest but also during ambulatory ECG monitoring and exercise tolerance testing.
每年全球有 150 万人因主要由心室颤动引起的心脏性猝死 (SCD) 而死亡。在 45%-50%的病例中,它是潜在心脏病的首发表现。包括吸烟、高血压、年龄、性别和左心室射血分数降低在内的传统危险因素,其敏感性和特异性均不足以预警即将发生的危及生命的心律失常。人们已经对心电图 (ECG) 的 SCD 风险标志物进行了长达数十年的研究。几个基于间期的指标,如 QT 离散度和 T-T 间期最初有一定的前景,但最终结果喜忧参半。最近,研究重点转向 R 波和 T 波形态的导联间异质性。新方法涉及到包括向量心电图技术和 QRS 对齐模板的二阶中心矩分析等先进的分析工具,以量化去极化和复极波形的异质性。目前研究的结果似乎是可靠的,值得进一步探索。这篇综述探讨了基于异质性的风险评估的电生理基础,并提供了临床技术的最新进展。我们还讨论了未来的方向,即通过跟踪异质性,不仅可以在静息时的心电图记录中,还可以在动态心电图监测和运动耐量测试中揭示潜在的 SCD 风险。